Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Rituximab and glatiramer acetate in secondary progressive multiple sclerosis: A randomized clinical trial.

  • Authors : Cheshmavar M; Isfahan Neurosciences Research Center, Alzahra Research Institute, Isfahan University of Medical Sciences, Isfahan, Iran.; Department of Neurology, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran.

Subjects: Glatiramer Acetate/Glatiramer Acetate/Glatiramer Acetate/*therapeutic use ; Immunosuppressive Agents/Immunosuppressive Agents/Immunosuppressive Agents/*therapeutic use ; Multiple Sclerosis, Chronic Progressive/Multiple Sclerosis, Chronic Progressive/Multiple Sclerosis, Chronic Progressive/*drug therapy

  • Source: Acta neurologica Scandinavica [Acta Neurol Scand] 2021 Feb; Vol. 143 (2), pp. 178-187. Date of Electronic Publication: 2020 Oct 27.Publisher: Wiley-Blackwell Country of Publication: Denmark NLM ID: 0370336 Publication Model: Print-Electronic Cited Medium:

تفاصيل العنوان

×
Academic Journal

Investigating the neuroprotective effect of Copolymer-1 in acute primary angle closure - Interim report of a randomized placebo-controlled double-masked clinical trial.

  • Authors : Fan KR; Singapore Eye Research Institute and Singapore National Eye Center, Singapore City, Singapore.; Baskaran M

Subjects: Glatiramer Acetate/Glatiramer Acetate/Glatiramer Acetate/*therapeutic use ; Glaucoma, Angle-Closure/Glaucoma, Angle-Closure/Glaucoma, Angle-Closure/*drug therapy ; Intraocular Pressure/Intraocular Pressure/Intraocular Pressure/*physiology

  • Source: Acta ophthalmologica [Acta Ophthalmol] 2019 Sep; Vol. 97 (6), pp. e827-e832. Date of Electronic Publication: 2019 Mar 27.Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 101468102 Publication Model: Print-Electronic Cited

تفاصيل العنوان

×
Academic Journal

Assessing the role of innovative therapeutic paradigm on multiple sclerosis treatment response.

  • Authors : Romeo MAL; Department of Neurology, Institute of Experimental Neurology, San Raffaele Scientific Institute, Milan, Italy.; Vita-Salute San Raffaele University, Milan, Italy.

Subjects: Immunosuppressive Agents/Immunosuppressive Agents/Immunosuppressive Agents/*therapeutic use ; Multiple Sclerosis, Relapsing-Remitting/Multiple Sclerosis, Relapsing-Remitting/Multiple Sclerosis, Relapsing-Remitting/*drug therapy ; Neurology/Neurology/Neurology/*trends

  • Source: Acta neurologica Scandinavica [Acta Neurol Scand] 2018 Nov; Vol. 138 (5), pp. 447-453. Date of Electronic Publication: 2018 Jul 22.Publisher: Wiley-Blackwell Country of Publication: Denmark NLM ID: 0370336 Publication Model: Print-Electronic Cited Medium:

تفاصيل العنوان

×
  • 1-10 of  107 نتائج ل ""GLATIRAMER acetate""